-
AstraZeneca posts $2.18bn profit after tax in Q1 2024
26 Apr 2024 10:42 GMT
… revenue from partnered medicines.
AstraZeneca’s oncology sector led … By GlobalData
AstraZeneca CEO Pascal Soriot said: “AstraZeneca had … industry-leading growth.”
AstraZeneca said the total dividend … and Drug Administration approved AstraZeneca’s FASENRA as …
-
Biopharma firm ANGLE signs supplier deal with AstraZeneca
26 Apr 2024 06:28 GMT
… signed a supplier agreement with AstraZeneca.
The Guildford firm has penned …
-
The drugs do work as AstraZeneca leads the pack
25 Apr 2024 22:53 GMT
… reports and renewed takeover activity.
AstraZeneca was the standout pharmaceuticals stock …
-
AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market with $4 billion in sales by 2027 from BioPharma-Reporter.com
25 Apr 2024 20:04 GMT
… GlobalData, said: “Amidst this progress, AstraZeneca and Merck voluntarily withdrew approval … through generic erosion.
“However, AstraZeneca's new selective PARP1 … castration-resistant prostate cancer, despite AstraZeneca and Merck’s voluntary withdrawal …
-
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
25 Apr 2024 19:24 GMT
… and higher costs meant AstraZeneca missed profit estimates.
However … $7.26 respectively.
AstraZeneca’s London-traded shares … now increasingly looking to AstraZeneca’s pipeline to determine … early-stage pipeline suggests AstraZeneca is exploring some higher- …
-
AstraZeneca on emerging markets, GLP-1 plans and why it’s selective about vaccines
25 Apr 2024 18:45 GMT
AstraZeneca put the spotlight on its …
-
AstraZeneca CEO says platform deals largely done after M&As in vaccines, radioligand, cell therapy
25 Apr 2024 17:59 GMT
After AstraZeneca’s recent acquisitions of various … .”
Soriot’s comment comes as AstraZeneca delivered a strong start to …
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 Apr 2024 17:47 GMT
… operations and financial performance of AstraZeneca. Although we believe our expectations … reflects the continuing strength of AstraZeneca's investment proposition for … think actually, across all geographic AstraZeneca emerging market has been growing …
-
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
25 Apr 2024 17:13 GMT
… Thursday, European drugmakers Sanofi and AstraZeneca announced several pipeline cuts in … a “strategic portfolio prioritization.”
Other AstraZeneca assets nixed for portfolio prioritization … compared to the same period. AstraZeneca meanwhile pulled in $12.1 …
-
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
25 Apr 2024 17:00 GMT
… F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, … ., Tetherex Pharmaceutical, CSL Behring, AstraZeneca, Novartis, Genentech, Vertex Pharmaceuticals … , 4D Pharma plc, AstraZeneca, Suzhou Connect Biopharmaceuticals, Avillion …